Company intelligence / Profile preview

Uetikon

Lahr, Baden-Württemberg, Germany

Ownership: Private
Employees: ~200
Development stage: Other

Overview

CU Chemie Uetikon is a specialized Contract Development and Manufacturing Organization (CDMO) focused on the production of high-quality fine chemicals and Active Pharmaceutical Ingredients (APIs). Headquartered in Lahr, Germany, the company provides custom synthesis and manufacturing services for the pharmaceutical and life sciences industries. Its capabilities include complex multi-step synthesis, hazardous chemistry, and GMP-compliant production. In 2015, the company was acquired by the Novacap Group, which later rebranded as Seqens, integrating Uetikon's expertise into a global pharmaceutical solutions platform.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Uetikon.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Uetikon.

Explore the full profile